The world’s hematologists are packing their bags in preparation for a visit to San Diego, California, for the American ...

Among important regulatory news last week, US drugmaker BridgeBio Pharma gained Food and Drug Administration (FDA) approval ...

Belgium’s largest drugmaker UCB on Friday announced the successful closing of the sale, divestment and license of its mature ...

During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian ...

Allink Biotherapeutics, a Chinese startup specializing in bispecific antibodies and antibody-drug conjugates, raises $42 ...

The Danish Ministry of Interior and Health has announced that the political parties have decided to permanently legalize ...

Minghui Pharmaceutical announces successful Phase III trial of MH004 for atopic dermatitis, achieving significant skin ...

AstraZeneca and Daiichi Sankyo’s breast cancer drug Enhertu to join China’s state health insurance in 2025, enhancing ...

Evotec's COO Craig Johnstone will leave by year-end as the company implements its Priority Reset restructuring amid declining ...

Indian drugmaker Dr Reddy’s Laboratories has launched its toripalimab in the domestic market, sending the firm’s share up 2%.

Galderma announces successful Phase III trial results for Nemluvio in treating prurigo nodularis, driving record trading ...

The Biden administration has proposed a new rule that could significantly expand Medicare and Medicaid coverage for obesity ...